Skip to main content

Take the fast track to becoming a V3 and V3+ expert

Establishing the business case for adoption of digital endpoints in clinical trials

By leveraging digital endpoints, clinical trials can be more patient-centric, data-driven, and adaptable to meet the evolving needs of healthcare research. Further, FDA recently qualified the first digital endpoint for clinical trials, which will revolutionize how outcomes are measured, enhancing accuracy and efficiency in research. 

And while digital endpoints’ potential is undeniable, widespread adoption remains a challenge. Decision-makers lack clear value assessments, routine use cases, and efficient deployment strategies around digital endpoints, hindering their numerous benefits. 

To address this, DATAcc by DiMe is developing a framework and resources to help you build a compelling case for continued investment in digital strategies aligning with business goals and industry standards. 

Helping you build a powerful business case

If you are a digital health innovator who needs to make a compelling business case for developing and implementing digital measures, these resources will empower you to do so. With them you can confidently advocate for the transformative potential of digital measure and emphasize advantages to decision-makers.

Stay up-to-date with this project and be among the first to access the project resources


Sign up to receive updates on this important work

This field is for validation purposes and should be left unchanged.

Project partners

    Unlocking the true potential of digital endpoints

    Findings from DiMe’s partnership with the Tufts Center for the Study of Drug Development and industry leaders at Johnson & Johnson, Roche, Genentech, UCB, Bayer, Takeda, and MindMed showcase evidence of significant cost reductions and financial benefits tied to leveraging digital endpoints in trials.

    We must continue to advance the use of digital endpoints to enhance clinical trials, leading to improved healthcare delivery.

    To benchmark the field’s progress, DATAcc by DiMe’s Library of Digital Endpoints highlights industry-sponsored studies of new medical products or applications to advance the use of digital endpoints to speed medical product development.

    Don’t miss your opportunity to join upcoming projects

    If you missed partnering on this project, don’t worry – we’ve got more exciting projects kicking off this year. Share your interest in either (or both) projects today!

    For pharma, tech, and digital health groups:

    The Playbook: Implementing AI in Healthcare

    For pharma and biotech:

    Enterprise Digital Health